O6-methylguanine Repair in Liver Cells in Vivo: Comparison Between G1- and S-phase of the Cell Cycle
Overview
Authors
Affiliations
To compare the formation and persistence of alkylated DNA bases in the G1- and S-phase compartments in liver in vivo, regenerating rat liver was exposed to [14C]dimethylnitrosamine (0.57 mg/kg, IP injection) or N-[methyl14C]-N-nitrosourea (3.3 mg/kg, intraportal injection) during the G1 phase of the cell cycle (12 h after partial hepatectomy), or at 24 h after partial hepatectomy with 30% hepatocytes in DNA synthesis, or at 43 h after partial hepatectomy, 4 h after an hydroxyurea block from 14 to 39 h after operation with 80% hepatocytes in DNA synthesis. At 120 min after dimethylnitrosamine and 90 s, 5, 10, or 60 min after the intraportal pulse of N-methyl-N-nitrosourea the molar fractions of 7-methylguanine (7megua), O6-methylguanine (O6megua), and 3-methyladenine (3mead) and of metabolically labeled guanine were determined from DNA hydrolysates by Sephadex-G10 radiochromatography. After dimethylnitrosamine only minor differences were observed for 7megua formation in the three groups; the 3mead/7megua ratio remained constant irrespective of the number of cells in S phase. In contrast, the O6megua/7megua ratio revealed a loss of O6megua, the extent of which appeared proportional to the fraction of DNA-synthesizing cells in the liver. The rapid loss of O6megua in S-phase cells was confirmed after intraportal administration of N-methyl-N-nitrosourea. During the first 10 min after the methylnitrosourea pulse the O6megua/7megua ratio was constant in G1 cells and dropped from 90 s to 10 min by about 15% in liver containing 30% S-phase cells and by about 40% with 80% cells in DNA synthesis. DNA-synthesizing hepatocytes are apparently endowed with a higher O6megua DNA transferase activity than nonproliferating liver cells. The rapid, though exhaustible elimination of O6megua during S-phase might result in partial protection of DNA-synthesizing cells from base-mispairing and/or from hypomethylation at G-C sites.
Schuster C, Rode G, Rabes H J Cancer Res Clin Oncol. 1985; 110(2):98-102.
PMID: 4044637 DOI: 10.1007/BF00402719.
Kunze E, Gassner G J Cancer Res Clin Oncol. 1986; 112(1):11-8.
PMID: 3733862 DOI: 10.1007/BF00394932.
Rabes H J Cancer Res Clin Oncol. 1986; 112(3):189-95.
PMID: 3536941 DOI: 10.1007/BF00395911.
Kunze E, Graewe T, Scherber S, Weber J, Gellhar P Br J Exp Pathol. 1989; 70(2):125-42.
PMID: 2730838 PMC: 2040540.
Kunze E, Konnecke B, Nienaber C Urol Res. 1990; 18(5):319-22.
PMID: 2256232 DOI: 10.1007/BF00300779.